Table of Contents
Volume 5 | Issue 5
Publication Date: March 2004- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
264 |
Smoking Cessation and Treatment Outcome Chandra P. Belani, Sakkaraiappan Ramalingam |
|
Researches in Brief | ||
267-269 |
Bisphosphonates to Prevent Skeletal Morbidity in Patients with Lung Cancer with Bone Metastases Nancy Price, Chandra P. Belani, Vinay K. Jain |
|
270-272 |
Evolving Role of Topotecan in Treating Small-Cell Lung Cancer G. Kesava Reddy, Chandra P. Belani, Vinay K. Jain |
|
Comprehensive Reviews | ||
274-289 |
Clinical Issues in the Management of Non–Small-Cell Lung Cancer and the Role of Platinum-Based Therapy Mark A. Socinski |
|
290-298 |
Integration of Multimodality Approaches in the Management of Malignant Pleural Mesothelioma Derlis Martino, Harvey I. Pass |
|
Original Contributions | ||
299-302 |
The Impact of Dose per Cycle of Etoposide and Cisplatin on Outcomes in Patients with Extensive Small-Cell Lung Cancer Harvey B. Niell, Said Beganovic, Sylvia Richey, Jim Y. Wan |
|
303-306 |
Megavoltage Computed Tomography Imaging: A Potential Tool to Guide and Improve the Delivery of Thoracic Radiation Therapy James S. Welsh, Kristin Bradley, Kenneth J. Ruchala, Thomas R. Mackie, Rafael Mañon, Rakesh Patel, Peggy Wiederholt, Michael Lock, Susanta Hui, Minesh P. Mehta |
|
Translational Medicine | ||
307-312 |
Genomic and Proteomic Analyses of Vascular Endothelial Growth Factor and Insulin-Like Growth Factor–Binding Protein 3 in Lung Adenocarcinomas Tarek G. Gharib, Guoan Chen, Chiang-Ching Huang, David E. Misek, Mark D. Iannettoni, Samir M. Hanash, Mark B. Orringer, David G. Beer |
|
Letter to the Editor | ||
313 |
Are Natural Products Still of Interest Compared with Molecular-Targeted Therapy for the Treatment of Cancer? Eric Raymond |
|